Completed
Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer
NCT02154737
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
- Locations
-
- UCSD Moores Cancer Center La Jolla, California, United States